Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Deciphera Pharmaceuticals

Founders Michael D. Taylor

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$52M
Portfolio companies 1
Rounds per year 0.06
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biotechnology
  • Health Care
Summary

Deciphera Pharmaceuticals is the famous Corporate Investor, which was founded in 2003. The leading representative office of defined Corporate Investor is situated in the Waltham. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Deciphera Pharmaceuticals Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund.

The fund was created by Michael D. Taylor.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Deciphera Pharmaceuticals, startups are often financed by SV Health Investors, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Sphera Global Healthcare Fund, Redmile Group.

The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017. The top amount of exits for fund were in 2017.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Deciphera Pharmaceuticals:
Typical Co-investors
Deciphera Pharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Deciphera Pharmaceuticals:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accrue Sports and Entertainment Ventures New York, New York, United States
Axa and main incubator -
Bob Pasker's Syndicate -
China Fortune Holdings Limited China, Hong Kong, New Territories
Comet Labs California, San Francisco, United States
CrowdStrike Falcon Fund California, Sunnyvale, United States
Earlybird England, London, United Kingdom
FoxKiser District of Columbia, United States, Washington
Guangzhou Qin Yue China, Guangdong, Guangzhou
IncuVest Central, Central Region, Singapore
IronGate Capital Advisors -
Just Eat England, London, United Kingdom
Launch LAB Greensboro, North Carolina, United States
Norte Ventures Brazil, São Paulo, Sao Paulo
San-in Godo Bank Japan, Matsue, Shimane Prefecture
SEQ Capital Partners Dubai, United Arab Emirates
Six Squared Capital Canada, Ontario, Toronto
SYBO Games Copenhagen, Denmark, Hovedstaden
Weicheng Juncheng Investment China, Fujian, Xiamen
Wisdom Sports Group China, Hong Kong, Hong Kong Island

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Deciphera Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$52M01 Jun 2017 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Deciphera Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 52M
Rounds per year 0.06
Peak activity year 2017
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Deciphera Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$52M01 Jun 2017 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: